ReviewCNS drugs2019

Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer's and Parkinson's Diseases.

Andre F Batista et al.PubMed ↗Publisher ↗

No numbers read from the abstract.